>>WALTHAM, Mass. -(Dow Jones)- Praecis Pharmaceuticals (NasdaqNM: PRCS - News) Inc.'s shareholders approved increasing authorized shares by 3 million shares.
As of March 31 , Praecis had 1,090,199 shares of common stock remained available for issuance under the amended 1995 stock Plan.
In a press release Wednesday, Praecis said shareholders also reauthorized Ernst & Young LLP as the company's independent auditors for fiscal 2002.
Ernst & Young served as independent auditor for the company in 2001 as well.
Praecis Pharmaceuticals shares traded recently at 3.20, up 6 cents, or 1.9%, on Nasdaq volume of 92,100 shares. Average daily volume is 439,572 shares.<<
Cheers, Tuck |
